The animal health division of Ranbaxy Laboratories Limited (Ranbaxy) has signed a marketing agreement with Alltech Biotechnology (Alltech) for YeaSacc*1026 Bolus, a highly valued product in the dairy cattle segment. Ranbaxy, with its prominent position in the Indian animal health industry, expects potential demand for products such as YeaSacc which will improve the productivity of Indian dairy animals, stated a press release.
Commenting on the agreement Chris King, General Manager, Alltech, India, said, "The product has a great fit for the Indian market" He added, "It boosts milk production by stimulating appetite, improving rumen function and results in increased milk yield and fat percentage. YeaSacc has demonstrated excellent results in numerous local and overseas trials, and the Indian market with its high roughage inclusion in the diet, is ideally suited to benefit from this product".
"The alliance will leverage and integrate the competencies of the Ranbaxy and Alltech and we expect to gain a leadership position in the market relatively quickly," said Dr Sanjay Chibber, Business Head, Animal Health Division, Ranbaxy. He further added, "Ranbaxy has built up an excellent understanding and service organization for the domestic market and Alltech is the world's leading Biotechnology company in the animal feed industry. This association will further strengthen and benefit the two organizations".
Ranbaxy and Alltech have plans for introducing more products in a phased manner. Alltech's global expertise, supported by Ranbaxy's leadership position in India, will benefit Indian customers immensely. India is the world's largest milk producer but the average Indian cattle farmer struggles with poor average milk yield and problems such as poor appetite and low fertility. The new commercial partnership between two leading companies has the potential to improve this current situation.
Kentucky-based Alltech is a world leader in the animal feed additive business. With an annual turnover of around $ 200 million, Alltech is present in 74 countries directly and through representation. It is also the only non-pharma company to be listed in the Top 20 Animal Health care companies worldwide. Alltech is committed to all natural solutions and developing products which are friendly to the Animal, Consumer & Environment.
Ranbaxy's Livestock business of the Animal Health Division is one of the fastest growing business among the Animal healthcare companies in India. Having started up an exclusive Strategic business unit for livestock products only in 2000, the company has catapulted itself into the fifth position in a short period of three years. The Company’s strengths are its team of seasoned and motivated professionals, an extensive network with thorough market coverage and its ability to identify the right segments and partners.